Recent research from 2025 investigates fulvic acid's potential immune-supporting and antiviral properties in context of viral challenges, specifically targeting its ability to interfere with viral attachment and reduce systemic inflammation.
Socol DC, et al. (2025). Cureus.
Clinical review shows humic/fulvic acid combination treatment benefits COVID-19 patients.
Pub version: Doctors found Fulvic helps people getting over viruses.
Winkler J, Ghosh S (2018). Journal of Diabetes Research.
Fulvic acid shows therapeutic potential for inflammatory diseases relevant to viral recovery.
Pub version: Fulvic helps stop bad swelling after being sick.